Univest Financial
- Market cap
- 1.13B
- P/E (TTM)i
- 11.88
- P/Bi
- 1.19
- EPSi
- 3.13
- Div yieldi
- 2.16%
- 52W posi
- 77%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Fair Value how this is computed
- Implied fair-value range of 25.66-36.94, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is +31.3% above the average-multiple fair value of 31.30.
Valuation each multiple against its own 5-year range
Vs. peers Banks - Regional
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Univest Financial (UVSP) | 1.13B | 11.88 | 1.19 | 2.16% |
| Mizuho Financial (MFG) | 129.28B | 16.71 | 1.81 | 1.64% |
| HDFC Bank (HDB) | 112.04B | 15.40 | 1.33 | 1.62% |
| Itau Unibanco (ITUB) | 108.62B | 11.77 | 2.50 | 6.08% |
| ICICI Bank (IBN) | 99.28B | 17.90 | 2.65 | 0.84% |
| U.S. Bancorp (USB) | 87.55B | 11.22 | 1.44 | 3.70% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 4.4% below Morningstar's fair value estimate.
Fair value
Univest Financial Corp is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 5% discount to our quantitative fair value estimate of $42.90 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 82.7%, which ranks in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.
Alternatively, the firm's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's sales yield of 28.5%, for example, lies in the bottom 30% globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which, despite our favorable price/fair value ratio, is a negative attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.
By Quantitative Equity Report
Quote time 2026-10-08 09:58:18 · For reference only, not investment advice and not tailored to your situation.